New Hikma CEO Eyes M&A, Upbeat Despite Generic Advair Woes

 
• By Kevin Grogan

 Sigurdur Olafsson is impressed with the balance sheet he has inherited at Hikma and said he is looking forward to both organic and inorganic growth.

Mirror
Hikma's copy of GSK's Advair needs more work • Source: Shutterstock

More from Deals

More from Business